+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Targeted DNA RNA Sequencing Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

  • PDF Icon

    Report

  • 190 Pages
  • February 2024
  • Region: Global
  • Infogence Global Research
  • ID: 5754602
Description Jump to:
The Global Targeted DNA RNA Sequencing Market is estimated to be USD 8.28 Bn in 2023 and is expected to reach USD 18.2 Bn by 2028 growing at a CAGR of 17.06%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global Targeted DNA RNA Sequencing Market is segmented based on Type, Method, Workflow, Application, End-User, and Geography.
  • >By Type, the market is classified into DNA Based Targeted Sequencing and RNA Based Targeted Sequencing.
  • By Method, the market is classified into NGS and Others.
  • By Workflow, the market is classified into Pre-sequencing, Sequencing, and Data Analysis.
  • By Application, the market is classified into Cancer gene sequencing, Inherited disease screening, Drug development, Forensic genomics, Ribosomal RNA (rRNA) sequencing, and Others.
  • By End User, the market is classified into Academic Research, Hospitals & Clinics, Pharma & Biotech Entities, and Others.
  • By Geography, the market is classified into Americas, Europe, Middle East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are F. Hoffmann-La Roche Ltd, Agilent Technologies, PierianDx, Knome Inc., Genomatix GmbH, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Targeted DNA RNA Sequencing Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Targeted DNA RNA Sequencing Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Targeted DNA RNA Sequencing Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth Market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 and the impact of economic slowdown & impending recession on the Market are also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Cost-Saving Advantages of the Adoption of a Targeted Sequencing Approach as well as Plummeting Sequencing Cost
4.1.2 Growing Advantages Associated with Targeted Gene Panels and Amplicon Sequencing
4.1.3 Increasing Advancements to Perform Sequencing in Less Time
4.2 Restraints
4.2.1 Limited access to Tools for Genomic Data Manipulation and Analysis
4.2.2 High-Cost Associated with Installation & Maintenance of Sequencing Facility
4.3 Opportunities
4.3.1 Rising Number of Targeted Sequencing-Based Research Projects and Consequent Popularity Growth of Genomic Medicine
4.3.2 Growing Technological Advancements in Sequencing Technology and Related Ancillary Protocols
4.3.3 Introduction of Digital Next-Generation Sequencing Technology
4.4 Challenges
4.4.1 Lack of Skilled & Trained Personnel
4.4.2 Bioinformatic Challenges Associated with Sequencing Technologies
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 SWOT Analysis
5.5 Impact of Covid-19
5.6 Impact of Economic Slowdown & Impending Recession
5.7 Ansoff Matrix Analysis
6 Global Targeted DNA RNA Sequencing Market, By Type
6.1 Introduction
6.2 DNA Based Targeted Sequencing
6.3 RNA Based Targeted Sequencing
7 Global Targeted DNA RNA Sequencing Market, By Technology
7.1 Introduction
7.2 NGS
7.2.1 Exome Sequencing
7.2.2 Enrichment Sequencing
7.2.3 Amplicon Sequencing
7.2.4 Others
7.3 Others(Sanger Sequencing, Fragment Analysis)
8 Global Targeted DNA RNA Sequencing Market, By Workflow
8.1 Introduction
8.2 Pre-sequencing
8.3 Sequencing
8.4 Data Analysis
9 Global Targeted DNA RNA Sequencing Market, By Application
9.1 Introduction
9.2 Human Biomedical Research
9.3 Plant & Animal Sciences
9.4 Drug Discovery
9.5 Others
10 Global Targeted DNA RNA Sequencing Market, By End-User
10.1 Introduction
10.2 Academic Research
10.3 Hospitals & Clinics
10.4 Pharma & Biotech Entities
10.5 Other
11 Americas' Targeted DNA RNA Sequencing Market
11.1 Introduction
11.2 Argentina
11.3 Brazil
11.4 Canada
11.5 Chile
11.6 Colombia
11.7 Mexico
11.8 Peru
11.9 United States
11.10 Rest of Americas
12 Europe's Targeted DNA RNA Sequencing Market
12.1 Introduction
12.2 Austria
12.3 Belgium
12.4 Denmark
12.5 Finland
12.6 France
12.7 Germany
12.8 Italy
12.9 Netherlands
12.10 Norway
12.11 Poland
12.12 Russia
12.13 Spain
12.14 Sweden
12.15 Switzerland
12.16 United Kingdom
12.17 Rest of Europe
13 Middle East and Africa's Targeted DNA RNA Sequencing Market
13.1 Introduction
13.2 Egypt
13.3 Israel
13.4 Qatar
13.5 Saudi Arabia
13.6 South Africa
13.7 United Arab Emirates
13.8 Rest of MEA
14 APAC's Targeted DNA RNA Sequencing Market
14.1 Introduction
14.2 Australia
14.3 Bangladesh
14.4 China
14.5 India
14.6 Indonesia
14.7 Japan
14.8 Malaysia
14.9 Philippines
14.10 Singapore
14.11 South Korea
14.12 Sri Lanka
14.13 Thailand
14.14 Taiwan
14.15 Rest of Asia-Pacific
15 Competitive Landscape
15.1 Competitive Quadrant
15.2 Market Share Analysis
15.3 Strategic Initiatives
15.3.1 M&A and Investments
15.3.2 Partnerships and Collaborations
15.3.3 Product Developments and Improvements
16 Company Profiles
16.1 Agilent Technologies, Inc.
16.2 BGI Group
16.3 Bio-Rad Laboratories, Inc.
16.4 DNASTAR, Inc.
16.5 F. Hoffmann-La Roche Ltd.
16.6 GATC Biotech Ag
16.7 Genomatix GmbH
16.8 Illumina, Inc.
16.9 Integrated DNA Technologies, Inc.
16.10 Knome, Inc.
16.11 Macrogen, Inc.
16.12 Oxford Nanopore Technologies
16.13 Pacific Biosciences of California, Inc.
16.14 Perkin Elmer, Inc.
16.15 PierianDx
16.16 QIAGEN N.V.
16.17 RainDance Technologies, Inc.
16.18 Thermo Fisher Scientific, Inc.
16.19 Hamilton Co.
16.20 Lucigen Corp.
17 Appendix
17.1 Questionnaire

Companies Mentioned

  • Agilent Technologies, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • DNASTAR, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GATC Biotech Ag
  • Genomatix GmbH
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Knome, Inc.
  • Macrogen, Inc.
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.
  • Perkin Elmer, Inc.
  • PierianDx
  • QIAGEN N.V.
  • RainDance Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Hamilton Co.
  • Lucigen Corp.

Related Topics

Copyright © 2002-2024 Research and Markets. All Rights Reserved.